Favicon of Rockwell Automation

Zhejiang Medicine Company Reduces Batch Review Cycle Time 46-75% with PharmaSuite MES

A documented Safety & Compliance Monitoring in Pharmaceuticals deployment at Zhejiang Medicine Company, with source-attributed results and missing evidence labelled explicitly.

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Evidence at a glance

Evidence status:
Automated evidence gate passed
Deployment timeframe:
Not reported by source
Reported outcome metrics:
3 cited below
Directory entry published:

The source-link check confirms reachability, not independent re-verification of every claim.

46-75%Batch Review Cycle Time Reduction
50%Management Review Cycle Time Reduction
5-10%Labor Cost Savings

Source-reported figures — cited source: rockwellautomation.com

The Challenge

Zhejiang Medicine Company's new Novus Pharmaceuticals subsidiary needed to transition to a completely paperless environment to meet FDA compliance requirements for its new antibiotic manufacturing facility serving U.S. and European regulated markets.

The Solution

ZMC implemented FactoryTalk PharmaSuite MES, which integrated production processes from the plant floor to the enterprise, with electronic batch records (EBR) digitizing paper records and automating document management for FDA 21 CFR Part 11 compliance.

Results

ZMC completely eliminated paper-based SOPs, hardcopy records, and equipment/material labels. Labor costs were reduced by 5-10%. Batch product review cycle time was reduced by 46-75%, and management-review cycle time was reduced by 50%.

Key Takeaways

  • Electronic batch records reduce batch review cycle times by 46-75% compared to paper-based pharmaceutical manufacturing documentation
  • Paperless MES implementation reduces labor costs 5-10% while simultaneously improving data integrity and regulatory compliance
  • Chinese pharmaceutical manufacturers targeting FDA-regulated markets must implement 21 CFR Part 11 compliant EBR systems as a prerequisite for product approval

Share:

Details

AI Technology
Not available in record
Company Size
Enterprise
Evidence status
Automated evidence gate passed
Deployment timeframe
Not reported by source
Directory entry published

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →